@article{435f120bd4ca45ce9b857fbeb8e5b252,
title = "Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized Medicine",
keywords = "Early patient access, Conditional approval, Accelerated approval, Personalized medicine, Drug development, Regulation, European Medicines Agency, Food and Drug Administration, Health technology assessment",
author = "Lada Leyens and Etienne Richer and Oyvind Melien and Wolfgang Ballensiefen and Angela Brand",
year = "2015",
doi = "10.1159/000437137",
language = "English",
volume = "18",
pages = "249--259",
journal = "Public Health Genomics",
issn = "1662-4246",
publisher = "Karger",
number = "5",
}